Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $71311.0.

  • iSpecimen's Change in Accured Expenses rose 12402.44% to $71311.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$305495.0, marking a year-over-year decrease of 536796.13%. This contributed to the annual value of -$371821.0 for FY2024, which is 406863.06% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Change in Accured Expenses is $71311.0, which was up 12402.44% from -$172687.0 recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Change in Accured Expenses peaked at $645675.0 during Q4 2022, and registered a low of -$2.3 million during Q2 2021.
  • Moreover, its 5-year median value for Change in Accured Expenses was $657.0 (2021), whereas its average is -$105360.4.
  • As far as peak fluctuations go, iSpecimen's Change in Accured Expenses soared by 9817625.57% in 2022, and later tumbled by 216465.15% in 2023.
  • Quarter analysis of 5 years shows iSpecimen's Change in Accured Expenses stood at $657.0 in 2021, then soared by 98176.26% to $645675.0 in 2022, then fell by 20.6% to $512647.0 in 2023, then crashed by 71.44% to $146413.0 in 2024, then tumbled by 51.29% to $71311.0 in 2025.
  • Its Change in Accured Expenses stands at $71311.0 for Q3 2025, versus -$172687.0 for Q2 2025 and -$350532.0 for Q1 2025.